AVTX vs NSC · P/E 0.0, $51.5M cap vs P/E 18, rev $6.46B
Avalo Therapeutics Inc (AVTX) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the AVTX and NSC stock pages for the full models.
Not investment advice.